Alnylam Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2834 http://www.alnylam.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

Alnylam's (ALNY) Impressive Pipeline Drives Share Price - Mar 18th, 2019 4:51 pm
See what the IHS Markit Score report has to say about Alnylam Pharmaceuticals Inc. - Mar 12th, 2019 8:32 am
Alnylam Files Application for Hypertension Candidate in UK - Mar 12th, 2019 7:59 am
Alnylam Submits CTA Application for ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension in High Unmet Need Settings - Mar 11th, 2019 5:00 am
Why Is Alnylam (ALNY) Up 3.1% Since Last Earnings Report? - Mar 9th, 2019 6:31 am
Alnylam to Webcast Presentation at Cowen & Company 39th Annual Health Care Conference - Mar 7th, 2019 2:00 pm
Alnylam Stock Down Despite Positive Phase III Givosiran Data - Mar 7th, 2019 7:00 am
Could This Biotech Sacrifice A Buy Point On Drug Safety Questions? - Mar 6th, 2019 2:10 pm
Side effects of Alnylam's gene-silencing drug raise concerns, shares slip - Mar 6th, 2019 9:06 am
Alnylam Pharmaceuticals stock down 7.5% after announcing results of Phase 3 givosiran trial - Mar 6th, 2019 7:12 am
After trial success, Alnylam plans to seek FDA approval for 2nd drug - Mar 6th, 2019 6:20 am
Alnylam Reports Positive Topline Results from ENVISION Phase 3 Study of Givosiran in Acute Hepatic Porphyria - Mar 6th, 2019 5:00 am
Can This Biotech Puppy Run With the Big Dogs? - Mar 4th, 2019 7:19 am
Medicines Company (MDCO) Q4 Loss Widens, Inclisiran in Focus - Feb 28th, 2019 7:50 am
Alnylam Announces Recipients of First Annual Advocacy for Impact Grants Program - Feb 28th, 2019 5:00 am
FDA panel says Karyopharm's cancer drug shows 'significant toxicity' - Feb 25th, 2019 4:43 am
Alnylam Pharmaceuticals Inc (ALNY) Files 10-K for the Fiscal Year Ended on December 31, 2018 - Feb 14th, 2019 4:48 pm
Is Moderna a Buy? - Feb 14th, 2019 10:01 am
Alnylam Pharmaceuticals Is Launched and Ready for More - Feb 12th, 2019 8:04 am